IL33 and neoplasm: Besides the direct delivery of IL-33, an interesting study reported endogenous IL-33 was released from stromal cells targeted by a lymphocytic choriomeningitis virus (LCMV)-based replication-competent vector delivering tumor-specific antigen to DC for efficient priming.